Document Detail


Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
MedLine Citation:
PMID:  19744259     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Cutaneous leishmaniasis (CL) is a disease caused by leishmania species. Intralesional sodium stibogluconate (SSG) has been considered the first line therapy for localized cutaneous leishmaniasis. There is still a need for more effective and less time-consuming therapeutic methods for this condition. OBJECTIVE: The aim of the present study was to investigate if the combination of intramuscular (IM) SSG or oral ketoconazole with intralesional (IL) SSG would be more effective than the intralesional SSG given alone in the treatment of localized cutaneous leishmaniasis. PATIENTS AND METHODS: Thirty patients with confirmed diagnosis of cutaneous leishmaniasis were included in the study. They were randomly assigned to three groups. The first group (10 patients with 12 lesions) was treated with intralesional SSG alone. The second group (10 patients with 15 lesions) was treated with the combination of intralesional SSG + intramuscular SSG. The third group (10 patients with 13 lesions) was treated with the combination of intralesional SSG and oral ketoconazole. A follow-up was performed every 4 weeks for a treatment period of 12 weeks, then monthly for a period of 6 months after the end of the treatment. RESULTS: Complete cure occurred in 58.3% of lesions in group 1, while 93.3% and 92.3% of lesions were cured in group 2 and 3 respectively. The difference between group 1 and the other groups was statistically significant (P < 0.05). CONCLUSION: Combined intramuscular SSG or oral ketoconazole with intralesional SSG is more effective than intralesional SSG alone for the treatment of CL. Oral ketoconazole is much easier and safer therapy than intramuscular SSG in combination with intralesional SSG in the treatment of localized cutaneous leishmaniasis.
Authors:
M El-Sayed; A E Anwar
Related Documents :
16903879 - An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-pip...
3044089 - Suppression of recurrent genital herpes by single daily dosages of acyclovir.
8589479 - Human leukocyte interferon-alpha in cream for the treatment of genital herpes in asian ...
10837169 - Combination treatment with famciclovir and a topical corticosteroid gel versus famciclo...
11262459 - Efficacy of maintenance therapy with topical boric acid in comparison with oral itracon...
25435159 - Antiadhesive effect of polyurethane foam packing in the guinea pig middle ear.
18846799 - Percutaneous vertebroplasty in osteoporotic vertebral compression fractures: our initia...
11034739 - Vitamin k antagonists or low-molecular-weight heparin for the long term treatment of sy...
24346769 - Short-term results of total ankle arthroplasty for end-stage ankle arthritis with sever...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2009-09-10
Journal Detail:
Title:  Journal of the European Academy of Dermatology and Venereology : JEADV     Volume:  24     ISSN:  1468-3083     ISO Abbreviation:  J Eur Acad Dermatol Venereol     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-05-14     Completed Date:  2010-10-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9216037     Medline TA:  J Eur Acad Dermatol Venereol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  335-40     Citation Subset:  IM    
Affiliation:
Department of Dermatology & Venereology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. body9995@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adolescent
Adult
Antifungal Agents / administration & dosage
Antimony Sodium Gluconate / administration & dosage*
Antiprotozoal Agents / administration & dosage
Child
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Injections, Intralesional
Injections, Intramuscular
Ketoconazole / administration & dosage*
Leishmaniasis, Cutaneous / drug therapy*,  pathology
Male
Middle Aged
Retrospective Studies
Skin / pathology
Time Factors
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Antifungal Agents; 0/Antimony Sodium Gluconate; 0/Antiprotozoal Agents; 65277-42-1/Ketoconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adnexal tumours of the skin as markers of cancer-prone syndromes.
Next Document:  The effect of an intervention aimed at reducing errors when administering medication through enteral...